checkAd

    Menstrual Cramps Treatment Market to Reach USD 841.6 Million, Globally, by 2031 at 4.1% CAGR  119  0 Kommentare AMR - Seite 2

    For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/15820 

    The drug stores and retail pharmacies segment dominated the market

    By distribution channel, the drug stores and retail pharmacies segment held the largest share in 2021, accounting for nearly three-fifths of the global menstrual cramps treatment market. This is due to increased sales of medicines from drug stores & retail pharmacies and increase in patients seeking treatment for menstrual cramps. However, the online providers segment is estimated to portray the highest CAGR of 4.9% from 2022 to 2031, due to increase in number of smartphone users and higher internet penetration to buy the medicines.

    North America held the largest share

    By region, the market across North America held the largest share in 2021, accounting for around two-fifths of the market, due to rise in government initiatives and well-developed healthcare infrastructure in this region. However, the global menstrual cramps treatment market across Asia-Pacific is projected to register the highest CAGR of 4.8% during the forecast period, owing to growth of the menstrual cramps treatment market in this region is the increase in prevalence of speech disorders.

    Key market players

    • Abbott Laboratories
    • AbbVie Inc.
    • Bayer AG
    • Dr. Reddy's Laboratories Ltd.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Pfizer Inc.
    • Sun Pharmaceutical Industries Ltd.

    Similar Research Reports for Information, Communication and Technology:

    Internet of Things in Healthcare Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

    Medical Tourism Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

    3D Cell Culture Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

    Neurovascular Devices Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

    Viral Vector and Plasmid DNA Manufacturing Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

    AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):

    AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

    Seite 2 von 3



    PR Newswire (engl.)
    0 Follower
    Autor folgen
    Verfasst von PR Newswire (engl.)
    Menstrual Cramps Treatment Market to Reach USD 841.6 Million, Globally, by 2031 at 4.1% CAGR AMR - Seite 2 Rise in demand for menstrual cramps treatment and surge in government support for healthcare infrastructure improvement have boosted the growth of the global menstrual cramps treatment market. PORTLAND, Ore., Dec. 2, 2022 /PRNewswire/ - Allied …